… randomized placebo-controlled trials. This review discusses the role of GLP-1 on the
cardiovascular system and addresses the impact of GLP-1-based therapies on CVD outcomes. …

… glycaemic control due to antidiabetic treatment. In our study, GLP-1 improved glycaemic control
… The weight loss within the GLP-1 group was significant but only reached ap value of 0·13 …

… of GLP-1 appears to be in relation to glycaemic control, there is growing evidence to suggest
that it may also play an important role in the cardiovascular system. GLP-1 receptors (GLP-…

… Long-term intensive glycaemic control reduces the risk of … shown a sustained effect on
glycaemic control of up to 3 years 56; … GLP-1 receptor agonists maintain glycaemic control for up to …

… , but initial improvement in glycaemic control often wanes over time, … for T2DM would improve
glycaemic control and beta-cell … Glucagon-like peptide-1 (GLP-1) receptor agonists such as …

… The beneficial effect on glycaemic control demonstrated in the … -1 levels after the injection.
Further studies using longer acting GLP-1 analogues are required to assess whether GLP-1 is …

… effect of liraglutide on glycaemic control in the present … substantial improvement in glycaemic
control in the exercise … the lack of improvement in glycaemic control despite an expected …

Aims: Most treatments for type 2 diabetes fail over time, necessitating combination therapy.
We investigated the safety, tolerability and efficacy of liraglutide monotherapy compared with …

… Introduced less than two decades ago, glucagon-like peptide-1 receptor agonists rapidly …
by providing glycaemic control in tandem with weight loss. However, FDA-approved GLP-1 …

… –1. We have demonstrated a significant improvement in postprandial glycaemic control with
s/c GLP-1 … GLP-1 improves glycaemic control even in the absence of an insulinotropic effect …